NeoGenomics Inc NEO
News
NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026
NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring
NeoGenomics Reports Second Quarter 2026 Results
NeoGenomics to Pay $9.8 Million to Resolve Allegations of False Claims Act Violation
